| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/21/2013 | EP2628733A1 Acylbenzene derivative |
| 08/21/2013 | EP2628725A1 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 08/21/2013 | EP2627346A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases |
| 08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
| 08/21/2013 | CN103261209A Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient |
| 08/21/2013 | CN103261197A Highly-soluble pyrroloquinoline quinone salt and method for producing same |
| 08/21/2013 | CN103254288A VEGFR2 tyrosine kinase inhibitor polypeptide and application thereof |
| 08/21/2013 | CN103254286A VEGFR2 tyrosine kinase inhibitor polypeptide and application thereof |
| 08/21/2013 | CN103254285A VEGFR2 tyrosine kinase inhibitor polypeptide and application thereof |
| 08/21/2013 | CN103254223A Silicon phthalocyanine axially modified by aminoethyl phenoxyl and polyethylene glycol oligomer |
| 08/21/2013 | CN103254177A Modulators of atp-binding cassette transporters |
| 08/21/2013 | CN103254172A Cytoskeletal active rho kinase inhibitor compounds, composition and use |
| 08/21/2013 | CN103251947A Scfv antibodies which pass epithelial and/or endothelial layers |
| 08/21/2013 | CN103251927A Composition containing bilberry extract |
| 08/21/2013 | CN103251818A Traditional Chinese medicinal composition for treating tinnitus |
| 08/21/2013 | CN103251744A Traditional Chinese medicine composition for treating keratitis and conjunctivitis |
| 08/21/2013 | CN103251725A Application of Chinese medicinal composition in preparation of drugs treating keratitis |
| 08/21/2013 | CN103251687A Compound traditional Chinese veterinary medicine premix for preventing and treating avian influenza |
| 08/21/2013 | CN103251633A Application of phenazopyridine in preparing anti-angiogenesis medicine |
| 08/21/2013 | CN103251632A Application of doxycycline in preparation of medicine for treating thyroid-associated ophthalmopathy |
| 08/21/2013 | CN103251631A Salicylate conjugates useful for treating metabolic disorders |
| 08/21/2013 | CN103251601A Use of carboxyamidotriazole (cai) orotate in macular degeneration |
| 08/21/2013 | CN103251592A Neurite formation promoter |
| 08/21/2013 | CN103251588A Application of phenytoin sodium in preparing anti-angiogenesis medicine |
| 08/21/2013 | CN103251579A Substituted acylanilides and methods of use thereof |
| 08/21/2013 | CN102626224B Eyesight improving agent composited by wild berries and Chinese medicines and preparation method thereof |
| 08/21/2013 | CN102600235B Chinese medicinal eye drop for treating oculopathy |
| 08/21/2013 | CN102552208B Daidzein solid dispersion micro-pill capsule and preparation method thereof |
| 08/21/2013 | CN102247477B Method for preparing bezoar soft capsules |
| 08/21/2013 | CN102210684B Application of ectoine and derivants thereof in preparation of medicament for treating cataract |
| 08/21/2013 | CN102106884B Medicinal composition having immunity-regulating function |
| 08/21/2013 | CN102070618B Compound and crystals thereof |
| 08/21/2013 | CN102050772B Bimatoprost crystal as well as preparation method and purposes thereof |
| 08/21/2013 | CN101970670B Methods for inhibiting angiogenesis using egfl8 antagonists |
| 08/21/2013 | CN101790517B Inhibitor of binding of s1p1 |
| 08/21/2013 | CN101600476B Punctal plugs and methods of delivering therapeutic agents |
| 08/20/2013 | US8513293 Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal |
| 08/20/2013 | US8513281 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 08/20/2013 | US8513279 Quinuclidine derivatives and medicinal compositions containing the same |
| 08/20/2013 | US8513220 Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activity |
| 08/20/2013 | US8512767 Pharmaceutical compositions |
| 08/20/2013 | US8512719 Oat extracts: refining, compositions and methods of use |
| 08/20/2013 | CA2515631C 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 08/19/2013 | CA2827869A1 Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient |
| 08/15/2013 | WO2013119988A1 Pharmaceutical compositions to reduce complications of ocular steroid |
| 08/15/2013 | WO2013117285A1 Furo [3, 2 - b] - and thieno [3, 2 - b] pyridine derivatives as tbk1 and ikk inhibitors |
| 08/15/2013 | WO2013041810A9 Stable, low-toxicity, sterilizable composition for ophthalmic dying |
| 08/14/2013 | EP2626112A1 A plant extract from the genus lindera for lowering intraocular pressure |
| 08/14/2013 | EP2624916A2 Compositions and methods for treating ocular edema, neovascularization and related diseases |
| 08/14/2013 | EP2624828A1 Picropodophyllin monohydrate or polymorph a in cancer therapy |
| 08/14/2013 | CN103249726A Acylbenzene derivative |
| 08/14/2013 | CN103249400A Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension |
| 08/14/2013 | CN103239707A Eye drop for treating myopia |
| 08/14/2013 | CN103239591A Medicine for treating eye diseases |
| 08/14/2013 | CN103239472A Novel medicinal application of fucoidan polysaccharide sulfate |
| 08/14/2013 | CN103239425A Pharmaceutical composition for the prolonged release of trimetazidine |
| 08/14/2013 | CN103239390A Tropicamide ophthalmic temperature-sensitive in-situ gel and preparation method thereof |
| 08/14/2013 | CN102138981B Preparation method of plantago seed polysaccharide extractive and applications thereof |
| 08/14/2013 | CN102026623B Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 08/14/2013 | CN101654470B Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 08/14/2013 | CN101486682B N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/13/2013 | US8507010 Compositions comprising quinazoline derivatives |
| 08/13/2013 | US8506987 Ocular implant made by a double extrusion process |
| 08/13/2013 | US8506962 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 08/13/2013 | US8506944 Replenishment and enrichment of ocular surface lubrication |
| 08/13/2013 | US8506539 Eyelid margin wipes comprising chemical means for temperature adjustment |
| 08/13/2013 | CA2690753C Sulfonamide compound and crystal thereof |
| 08/13/2013 | CA2592474C Prostaglandin f2.alpha. derivative-containing product |
| 08/13/2013 | CA2580409C Triazole derivative or salt thereof |
| 08/13/2013 | CA2543406C Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 08/08/2013 | WO2013113067A1 Improvements in tear film stability |
| 08/08/2013 | US20130203834 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 08/08/2013 | US20130203833 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 08/07/2013 | EP2623494A1 Agent for treatment of eye diseases |
| 08/07/2013 | EP2623491A2 Piperidine and piperazine derivatives as autotaxin inhibitors |
| 08/07/2013 | EP2623490A1 2-(3-aminophenoxy)-acetic acid derivatives as EP2 receptor agonists for use in treatment of glaucoma |
| 08/07/2013 | CN103237551A Pharmaceutical formulation having neuroprotective activity |
| 08/07/2013 | CN103232931A Vitamin, microelement and pine pee series health-care snake medicinal liquor for prolonging life |
| 08/07/2013 | CN103232543A Recombinant protein Tumstatin-CD137L4 with Tumstatin activities as well as preparation method and application thereof |
| 08/07/2013 | CN103232540A Domain antibody construct |
| 08/07/2013 | CN103230589A Fibrinogen compound and application thereof |
| 08/07/2013 | CN103230410A Application of zinc gluconate tablet and six-vitamin pill in treatment of ocular ametropia |
| 08/07/2013 | CN103230362A In-situ gel for injecting flunixin meglumine and preparation method thereof |
| 08/07/2013 | CN103230002A DHA (docosahexaenoic acid) liposome preparation method |
| 08/07/2013 | CN102697713B Sodium hyaluronate eye drops and a preparation method thereof |
| 08/07/2013 | CN102670853B Traditional Chinese medicine ear lotion for preventing and curing tinnitus |
| 08/07/2013 | CN102626436B Preparation method of liuwei eyesight improving pharmaceutical composition |
| 08/07/2013 | CN102614252B Prescription for treating cataract |
| 08/07/2013 | CN102579778B Traditional Chinese medicine for treating Behcet disease and Behcet syndrome |
| 08/07/2013 | CN102389500B Heat clearing and detoxifying oral solution |
| 08/07/2013 | CN102370710B Medicament for treating otitis media and preparation method thereof |
| 08/06/2013 | US8501791 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/06/2013 | US8501756 Heterobicyclic carboxamides as inhibitors for kinases |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | US8501423 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 08/06/2013 | CA2714081C Methods and compositions for treating conditions of the eye |
| 08/06/2013 | CA2609388C Novel piperidine derivative |
| 08/06/2013 | CA2586345C Method of obtaining derivatives of 4-(n-alkylamine)-5,6-dihydro-4h-thieno-[2,3-b]-thiopyran |
| 08/06/2013 | CA2526509C Connective tissue growth factor antibodies |
| 08/06/2013 | CA2520957C Method for treating vascular hyperpermeable disease |